Maynard Um
-
-
-
-
-
-
-
BridgeBio Oncology Therapeutics (BBOT) Reiterated at Buy by Stifel After Q4 Results
-
-
-
-
-
-
-
BBOT reports clinical data for three cancer drug candidates
-
-
-
-
-
-
-
Cantor Fitzgerald Starts BridgeBio Oncology Therapeutics, In (BBOT) at Overweight
-
433,570 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

